Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
6.30
-0.16 (-2.48%)
May 15, 2026, 12:26 PM EDT - Market open
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.56 billion as of May 15, 2026. Its market cap has increased by 18.60% in one year.
Market Cap
1.56B
Enterprise Value
1.59B
1-Year Change
18.60%
Ranking
Category
Stock Price
$6.30
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.56B, an increase of 541.24%. That is a compound annual growth rate of 16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 1.60B | 12.66% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 1.69B |
| Nuvation Bio | 1.69B |
| Vericel | 1.68B |
| Innoviva | 1.68B |
| Recursion Pharmaceuticals | 1.67B |
| Nurix Therapeutics | 1.65B |
| Monte Rosa Therapeutics | 1.61B |
| Iovance Biotherapeutics | 1.59B |